💊 Препараты А-Я 🧬 Мишени 🛠 Инструменты 📚 Руководства
Все препараты Классы препаратов Терапевтические области Побочные Эффекты
Руководства Глоссарий Хронология
Сравнения Путешествия препаратов Группы лекарственных средств
🇺🇸 English 🇰🇷 한국어 🇯🇵 日本語 🇨🇳 中文简体 🇪🇸 Español 🇧🇷 Português 🇮🇳 हिन्दी 🇸🇦 العربية 🇫🇷 Français 🇷🇺 Русский 🇩🇪 Deutsch 🇹🇷 Türkçe 🇻🇳 Tiếng Việt 🇮🇩 Bahasa Indonesia 🇹🇭 ไทย

Technetium Tc 99M Oxidronate

CHEMBL1200415 Phase 4 Одобрено Small molecule
Half-Life
—
Bioavailability
—
Protein Binding
—
Molecular Weight
290.9 g/mol
LogP
—
Phase
4

Technetium Tc 99m oxidronate (99mTc-HDP) is a diphosphonate bone-seeking radiopharmaceutical used for skeletal scintigraphy to detect bone metastases from breast cancer, assess cardiac amyloidosis, and evaluate metabolic bone disease and heart failure-related conditions. See technetium-oxidronate for complete pharmacological details. It offers favorable imaging characteristics for bone and cardiac applications.

Молекулярная масса

290,9100 g/mol

TPSA

135,00 Ų

Терапевтические области

Breast Cancer Heart Failure

Механизм действия

Contains a radioactive isotope that accumulates in specific tissues or organs, enabling detection and imaging of physiological processes or pathological conditions using nuclear medicine techniques.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Механизм

Contains a radioactive isotope that accumulates in specific tissues or organs, enabling detection and imaging of physiological processes or pathological conditions using nuclear medicine techniques.

SMILES

C(O)(P(=O)(O)O)P(=O)(O)O.[99Tc]

InChI

InChI=1S/CH6O7P2.Tc/c2-1(9(3,4)5)10(6,7)8;/h1-2H,(H2,3,4,5)(H2,6,7,8);/i;1+1

Molecular Formula

CH6O7P2Tc

HBD / HBA

5 / 7

Вращаемые Связи

2

Тяжёлые Атомы

11

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Часто задаваемые вопросы

Technetium Tc 99m oxidronate (99mTc-HDP) is a diphosphonate bone-seeking radiopharmaceutical used for skeletal scintigraphy to detect bone metastases from breast cancer, assess cardiac amyloidosis, and evaluate metabolic bone disease and heart failure-related conditions. See technetium-oxidronate for complete pharmacological details. It offers favorable imaging characteristics for bone and cardiac applications.

Contains a radioactive isotope that accumulates in specific tissues or organs, enabling detection and imaging of physiological processes or pathological conditions using nuclear medicine techniques.

Yes, Technetium Tc 99M Oxidronate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200415. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 123801. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Медицинский отказ от ответственности

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.